Author: OurCrowd

Newsletter: Airbnb, DoorDash & DropBox incubator

Top investment opportunities Startup of the week: OncoHost Rebel Fund: Nurturing the next DoorDash and Airbnb Canadian clearance for our flagship OC50 Fund Cyabra nails sock puppets in China-Australia spat SALT Talks: Tech cure for fake news and deepfakes Douxmatok pleases palates of top UK chefs Bizzabo powers through pandemic, raises $138M Sight Diagnostics sets sights on Gulf with Phoenix Zebra Med scores seventh FDA clearance for AI imaging Gil Meron appointed CEO of our New Zealand incubator Introductions: Can your contacts help our startups grow? Job opportunities Startup of the week: OncoHost OncoHost is using artificial intelligence software to revolutionize the $275B market (2025) for immunotherapy cancer drugs. Their use of AI and protein analysis can “predict response to immunotherapy and provide clinicians with potential combination strategies in order to overcome treatment resistance,” CEO Dr. Ofer Sharon told futurist and BlockVentures CEO Antoine Tardif. “Our chief scientist, Prof. Yuval Shaked, now the head of the integrated cancer research center at the Technion-Israel Institute of Technology, discovered that the host response to anti-cancer treatment may facilitate and support tumor...

Read More

[Quantum Machines in Forbes] Quantum Machines Aims To Bridge The Digital And Analog Worlds

“Quantum computing does not promise us better computing. It promises impossible computing,” says Itamar Sivan, CEO and co-founder of Quantum Machines, a Tel-Aviv-based startup. Founded two years ago, it has raised $23 million from Battery Ventures and others. “For a startup company,” says Sivan, “we have very substantial revenues—we sell to everyone who is in the quantum computing race.” Read more...

Read More